• Filing Date: 2020-11-09
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Common Stock
Series B
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 18,767,619 240,861      
Beginning balance, amount at Dec. 31, 2018 $ 2 $ 0 $ 15,518 $ (12,064) $ 3,456
Stock-based compensation     314   314
Issuance of common stock pursuant to exchange agreement, amount         0
Issuance of warrants in conjunction with notes payable     706   706
Exercise of cashless warrants in exchange for common stock 828,541        
Exercise of warrants in exchange for common stock 103,125        
Exercise of warrants in exchange for common stock, amount     103   103
Common stock issued in OpenALPR Technology acquisition, shares 600,000        
Common stock issued in OpenALPR Technology acquisition, amount     397   397
Issuance of common stock pursuant to at the market offering net, shares 103,566        
Issuance of common stock pursuant to at the market offering net, amount     38   38
Exercise of warrants related to series A preferred stock, shares 3,638        
Exercise of warrants related to series A preferred stock, amount     4   4
Preferred stock dividends       (344) (344)
Accretion of Series A preferred stock     (554)   (554)
Net loss (11,428) (11,428)
Ending balance, shares at Sep. 30, 2019 20,406,489 240,861      
Ending balance, amount at Sep. 30, 2019 $ 2 $ 0 16,526 (23,836) (7,308)
Beginning balance, shares at Jun. 30, 2019 19,382,185 240,861      
Beginning balance, amount at Jun. 30, 2019 $ 2 $ 0 16,496 (20,094) (3,596)
Stock-based compensation     76   76
Exercise of cashless warrants in exchange for common stock 813,975        
Exercise of warrants in exchange for common stock 103,125        
Exercise of warrants in exchange for common stock, amount     103   103
Issuance of common stock pursuant to at the market offering net, shares 103,566        
Issuance of common stock pursuant to at the market offering net, amount     38   38
Exercise of warrants related to series A preferred stock, shares 3,638        
Exercise of warrants related to series A preferred stock, amount     4   4
Preferred stock dividends       (114) (114)
Accretion of Series A preferred stock     (191)   (191)
Net loss (3,628) (3,628)
Ending balance, shares at Sep. 30, 2019 20,406,489 240,861      
Ending balance, amount at Sep. 30, 2019 $ 2 $ 0 16,526 (23,836) (7,308)
Beginning balance, shares at Dec. 31, 2019 21,595,653 240,861      
Beginning balance, amount at Dec. 31, 2019 $ 2 $ 0 19,731 (28,408) (9,035)
Stock-based compensation     539   539
Issuance of common stock pursuant to exchange agreement, shares 4,349,497        
Issuance of common stock pursuant to exchange agreement, amount     17,325   17,325
Exercise of cashless warrants in exchange for common stock 214,740        
Exercise of warrants in exchange for common stock 1,180,000        
Exercise of warrants in exchange for common stock, amount     874   874
Issuance of common stock pursuant to at the market offering net, shares 5,216,562        
Issuance of common stock pursuant to at the market offering net, amount $ 1   29,929   29,930
Exercise of warrants related to series A preferred stock, shares 74,177        
Exercise of warrants related to series A preferred stock, amount     77   77
Issuance upon exercise of stock options, shares 281,225        
Issuance upon exercise of stock options, amount     640   640
Preferred stock dividends       (345) (345)
Accretion of Series A preferred stock     (638)   (638)
Net loss (11,075) (11,075)
Ending balance, shares at Sep. 30, 2020 32,911,854 240,861      
Ending balance, amount at Sep. 30, 2020 $ 3 $ 0 68,117 (39,828) 28,292
Beginning balance, shares at Jun. 30, 2020 22,942,546 240,861      
Beginning balance, amount at Jun. 30, 2020 $ 2 $ 0 22,180 (33,044) (10,862)
Stock-based compensation     202   202
Issuance of common stock pursuant to exchange agreement, shares 4,349,497        
Issuance of common stock pursuant to exchange agreement, amount     17,325   17,325
Exercise of cashless warrants in exchange for common stock 171,522        
Exercise of warrants in exchange for common stock 625,000        
Exercise of warrants in exchange for common stock, amount     463   463
Issuance of common stock pursuant to at the market offering net, shares 4,677,595        
Issuance of common stock pursuant to at the market offering net, amount $ 1   27,752   27,753
Exercise of warrants related to series A preferred stock, shares 16,214        
Exercise of warrants related to series A preferred stock, amount     17   17
Issuance upon exercise of stock options, shares 129,480        
Issuance upon exercise of stock options, amount     398   398
Preferred stock dividends       (115) (115)
Accretion of Series A preferred stock     (220)   (220)
Net loss (6,669) (6,669)
Ending balance, shares at Sep. 30, 2020 32,911,854 240,861      
Ending balance, amount at Sep. 30, 2020 $ 3 $ 0 $ 68,117 $ (39,828) $ 28,292